Starke Menstruationsblutungen
Studien
Deutsche Studien
- C. Altgassen, B. Bojahr, K. Diedrich, A. Gallinat, R. Kreienberg, G. Kreuz, T. Römer, R. Söder, D. Wallwiener: ENDOMETRIUMABLATION - Operative, organerhaltende Behandlung der dysfunktionellen uterinen Blutung, FRAUENARZT 3/2010
- Gallinat A, Schmidt T: Operative Behandlungsverfahren für dysfunktionelle uterine Blutungen, Ein Kosten-Nutzen-Vergleich, FRAUENARZT 2/2009
- Gallinat A: NovaSure® Impedance-Controlled System for Endometrial Ablation: Three-year Follow-up on 107 Patients. Am J Obstet Gynecol 2004;191(5):1585-9.
- Gallinat A, Nugent W: NovaSure® Impedance-Controlled System for Endometrial Ablation. J Am Assoc Gynecol Laparoscop 2002;9(3):283-9.
- Gallinat A: An Impedance-Controlled System for Endometrial Ablation: Five-Year Follow-up of 107 Patients. J Reprod Med 2007;5296):467-72
- Hucke J.: Operative Optionen bei Myomen und Adenomyosis uteri, gynäkologie + geburtshilfe 3/2008
- Römer T, Socko P, Kreuz G: Hochfrequenzablation versus transzervikale Endometriumresektion, Prospektive klinische Vergleichsstudie zur Behandlung der rezidivierenden Hypermenorrhoe, FRAUENARZT 10/2010
Internationale Studien
- Abbott J, Hawe J, Hunter D, Garry R: A double-blind randomized trial comparing the Cavaterm™ and the NovaSure® endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003;80(1):203-8.
- Abbott J, Hawe J, Garry R: Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Am Assoc Gynecol Laparosc 2003;10(4):491-5.
- AlHilli, Mariam M., MB, BCh, Matthew R. Hopkins, MD, and Abimbola O. Famuyide, MBBS: Endometrial Cancer After Endometrial Ablation: Systematic Review of Medical Literature.
Journal of Minimally Invasive Gynecology (2011) 18, 393–400 _ 2011 AAGL
- Baskett T, Clough H, Scott T: NovaSure Bipolar Radiofrequency Endometrial Ablation: Report of 200 Cases. J Obstet Gynaecol Can 2005;27(5):473-6.
- Bongers MY, Bourdrez P, Heintz AP, Brolmann HA, Mol BW.: Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: impact on patients' health-related quality of life. Fertil Steril 2005;83(3):724-34.
- Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H: Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. Obstet Gynecol Surv 2005;60(2):93-4.
- Bongers M, Bourdrez P, Mol B, Heintz A, Brolmann H: Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG 2004;111:1095–1102.
- Bradley L: New endometrial ablation techniques for treatment of menorrhagia. Surg Technol Int 2004;12:161-70.
- Busund B, Erno L, Gronmark A, Istre O: Endometrial ablation with NovaSure® GEA, a pilot study. Acta obstetricia et gynecologica Scandinavica. 2003;82(1):65-8.
- Cooper J, Gimpleson R: Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49(4):267-73.
- Cooper J, Gimpleson R, Laberge P, Galen D, Garza-Leal J, Scott J, Leyland N, Martyn P, Liu J: A randomized, multicenter trial of safety and efficacy of the NovaSure® System in the treatment of menorrhagia. J Am Assoc Gynecol Laparoscop 2002;9(4):418-28.
- Cooper J: NovaSure® GEA Technology Overview. Analysis of Worldwide Clinical Results. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001.
- Cooper J, Brill A, Fulop T. Is endometrial pretreatment necessary in NovaSure 3-D endometrial ablation? Gynaecologic Endoscopy 2001 10(3):179-82.
- Deb S, Flora K, Atiomo W. A survey of preferences and practices of endometrial ablation/resection for menorrhagia in the United Kingdom. Fertil Steril 2007; Dec 14 [Epub ahead of print].
- Donnadieu AC, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation. Int J Gynecol Obstet 2007; March 20 [Epub ahead of print].
- Della Badia C, Nyirjesy P, Atogho A. Endometrial ablation devices: Review of a manufacturer and user facility device experience database. J Minim Invasive Gynecol 2007;14:436-41.
- Dickersin K, Munro MG, Clark M, et al; for the Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Research Group. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2007;110(6):1279-1289.
- El-Nashar SA, Hopkins M, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, Cliby WA, Famuyide AO.Global Endometrial Ablation for Menorrhagia in Women With Bleeding Disorders. Obstet and Gynecol 2007:109(6):1381-7.
- El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, Cliby WA, Famuyide AO. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol. 2009 Jan;113(1):97-106.
- Fadare O, Qin L, Martel M, tavassoli FA: Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system. Arch Pathol Lab Med 2005;129(9):1175-8.
- Fulop T, Rakoczi I, Barna I. NovaSure impedance controlled endometrial ablation: Long-term follow-up results. J Minim Invasive Gynecol 2007;14(1):85-90.
- Fulop T, Rakoczi I, Barna I: NovaSure® Impedance Controlled Endometrial Ablation System. Long-term Follow-up Results. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001.
- Gallinat A: NovaSure® Impedance-Controlled System for Endometrial Ablation: Three-year Follow-up on 107 Patients. Am J Obstet Gynecol 2004;191(5):1585-9.
- Gallinat A, Nugent W: NovaSure® Impedance-Controlled System for Endometrial Ablation. J Am Assoc Gynecol Laparoscop 2002;9(3):283-9.
- Gallinat A: An Impedance-Controlled System for Endometrial Ablation: Five-Year Follow-up of 107 Patients. J Reprod Med 2007;5296):467-72
- Glazerman L. Patient Satisfaction After Radiofrequency Endometrial Ablation. Obstetrics and Gynecology 2008;111(4):79S.
- Hopkins MR, Creedon DJ, El-Nashar SA, Brown DL, Good AE, Famuyide AO. Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. J Minim Invasive Gynecol 2007;14(4):494-501
- Kleijn JH, Engels R, Bourdrez P, Mol BWJ, Bongers MY. Five-year follow up of a randomized controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 2008;115(2):193-8
- Laberge P, Sabbah R, Fortin C, Gallinat A: Assessment and Comparison of Intraoperative and Postoperative Pain Associated with NovaSure® and ThermaChoice Endometrial Ablation Systems. J Am Assoc Gynecol Laparoscop 2003;10(2):223-32.
- Laberge P: NovaSure GEA Technology Overview. 2nd World Congress on Controversies in Obstetrics, Gynecology & Infertility; Paris, France; September 6-9, 2001.
- Lukes, Andrea S., MD*, Ryan J. McBride, PhD, Amy H. Herring, ScD, Michael Fried, MD, Atiya Sherwani, and Diana Dell, MD: Improved
Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation.
- Munro MG. Endometrial ablation: where have we been? Where are we going? Clin Obstet Gynecol. 2006 Dec;49(4):736-66.
- Sabbah R, Desaulniers G. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J Minim Invasive Gynecol 2006;13(5):467-71.
- Sharp H. Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and Uterine Leiomyomata. Obstet and Gynecol 2006;108(4):990-1003.
- Zarek S, Sharp HT. Global endometrial ablation devices. Clin Obstet Gynecol. 2008 Mar;51(1)::167-75
Hormon Therapie / Hormonfreisetzende Spirale
- Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. Br J Obstet Gynaecol. 2000;107(3):335-339.
- Busfield RA, Farquhar CM, Sowter MC, et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG. 2006;113(3):257-263.
- Cooper KG, Jack SA, Parkin DE, Grant AM. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br J Obstet Gynaecol. 2001;108(12):1222-28.
- Davis A, Godwin A, Lippman J, Olson W, Kafrissen M. Triphasic norgestimateethinyl estradiol for treating dysfunctional uterine bleeding. Obstet Gynecol. 2000;96(6):913-920.
- Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized 5-year follow-up. JAMA 2004;291(12):1456-63.